National Peroxide Ltd Upgraded to Buy on Improved Technicals and Attractive Valuation

Technical Outlook Shifts to Mildly Bullish

The upgrade was primarily triggered by a notable improvement in the technical trend for National Peroxide Ltd. The technical grade shifted from a sideways pattern to a mildly bullish stance, signalling a potential upward momentum in the stock price. Key technical indicators support this positive outlook. The weekly MACD (Moving Average Convergence Divergence) is bullish, suggesting strengthening momentum, while the monthly Bollinger Bands indicate a bullish trend. Additionally, the weekly KST (Know Sure Thing) and Dow Theory assessments are mildly bullish, reinforcing the positive technical sentiment.

However, some caution remains as the daily moving averages still show a mildly bearish signal, and the RSI (Relative Strength Index) on both weekly and monthly charts currently provide no clear signal. Despite these mixed signals, the overall technical picture has improved sufficiently to warrant an upgrade in the technical grade, reflecting a more favourable environment for potential price appreciation.

Valuation Moves from Very Attractive to Attractive

Alongside technical improvements, valuation metrics have also evolved, prompting a re-rating of the stock’s attractiveness. The valuation grade has been upgraded from very attractive to attractive, reflecting a more balanced but still favourable price level relative to earnings and book value. National Peroxide currently trades at a price-to-earnings (PE) ratio of 30.31, which, while higher than some peers, remains reasonable given the company’s growth prospects and sector context.

The price-to-book (P/B) value stands at 0.97, indicating the stock is trading just below its book value, a sign of potential undervaluation. Enterprise value to EBITDA (EV/EBITDA) is 9.38, which is attractive compared to many industry peers, some of which are trading at significantly higher multiples. The PEG ratio is exceptionally low at 0.05, signalling that the stock’s price growth is not yet fully reflective of its earnings growth potential. Return on capital employed (ROCE) and return on equity (ROE) are modest at 3.44% and 3.21% respectively, suggesting room for operational improvement but consistent profitability.

Financial Trend Shows Strong Quarterly Performance

National Peroxide’s financial trend has been a key factor in the rating upgrade. The company reported very positive results for the quarter ending March 2026, with net profit surging by 333.33% year-on-year. This remarkable growth was accompanied by the highest quarterly net sales of ₹85.68 crores and a PBDIT (Profit Before Depreciation, Interest and Taxes) of ₹14.88 crores, the highest recorded in recent periods. The operating profit margin to net sales also reached a peak of 17.37%, underscoring improved operational efficiency.

Importantly, the company is net-debt free, which strengthens its financial position and reduces risk for investors. The positive quarterly momentum follows two consecutive quarters of favourable results, signalling a sustained recovery or growth phase. However, it is worth noting that over the longer term, the company has experienced a decline in net sales and operating profit at annual rates of -6.72% and -24.68% respectively over the past five years, highlighting some structural challenges.

Quality Assessment and Market Capitalisation

National Peroxide holds a Mojo Score of 70.0 and a Mojo Grade of Buy, upgraded from Hold on 18 May 2026. The company is classified as a micro-cap stock within the commodity chemicals sector, which often entails higher volatility but also potential for outsized returns. The quality grade reflects the company’s improving fundamentals and technical outlook, although some caution remains due to its modest returns on equity and capital employed.

Shareholding remains concentrated with promoters holding the majority stake, which can be a positive factor for stability and strategic direction. The stock price currently stands at ₹602.10, unchanged from the previous close, with a 52-week high of ₹770.00 and a low of ₹350.00, indicating a wide trading range and potential for recovery.

Stock Performance Relative to Sensex

Examining returns relative to the benchmark Sensex index reveals a mixed but generally positive picture for National Peroxide. Over the past month, the stock has delivered a robust 48.37% return, significantly outperforming the Sensex’s decline of 4.05%. Year-to-date, the stock has gained 28.65%, while the Sensex has fallen by 11.62%. Over the past year, the stock’s return is marginally positive at 0.43%, compared to the Sensex’s negative 8.22%.

These figures suggest that despite short-term volatility, National Peroxide has demonstrated resilience and growth potential relative to the broader market. However, longer-term returns over three, five, and ten years are not available for the stock, while the Sensex has delivered strong gains over these periods, indicating that investors should weigh the company’s micro-cap risks against its recent outperformance.

Risks and Considerations

While the upgrade to Buy is supported by improved technicals, attractive valuation, and strong recent financial performance, investors should remain mindful of certain risks. The company’s long-term growth has been subdued, with negative compound annual growth rates in net sales and operating profit over five years. This raises questions about sustainable growth prospects and competitive positioning within the commodity chemicals industry.

Moreover, the relatively low returns on equity and capital employed suggest that operational efficiency and profitability could improve further. The stock’s micro-cap status also implies higher liquidity risk and potential price volatility. Investors should consider these factors alongside the positive developments when making investment decisions.

Conclusion: A Balanced Upgrade Reflecting Positive Momentum

The upgrade of National Peroxide Ltd’s investment rating to Buy reflects a confluence of factors that have improved the company’s outlook. Enhanced technical indicators suggest a shift towards bullish momentum, while valuation metrics remain attractive relative to peers, supported by a low PEG ratio and reasonable price-to-book value. The company’s recent financial results demonstrate strong quarterly growth and a net-debt-free balance sheet, which underpin confidence in its near-term prospects.

Nevertheless, investors should remain cautious about the company’s longer-term growth challenges and modest profitability ratios. The micro-cap nature of the stock adds an element of risk, but also potential reward for those willing to engage with the commodity chemicals sector’s dynamics. Overall, the upgrade signals a positive directional change, making National Peroxide Ltd a stock to watch for investors seeking exposure to this niche industrial segment.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →